clinical trial · NCT02500316
Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Growth Hormone Deficiency (GHD)MOD-4023
brief summary
Protocol CP-4-004-OLE (Open Label Extension) is designed as a long-term, open-label extension using single patient use, multi-dose, disposable pre-filled pen.
started
Feb 1, 2014
primary completion
Nov 1, 2023
completion
Nov 1, 2023
last updated
Apr 9, 2025
official title
Safety and Dose Finding Study of Different MOD-4023 Dose Levels Compared to Daily R-human Growth Hormone (hGH) Therapy in Pre-pubertal Growth Hormone Deficient Children
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol